THE ANGIOPOIETIN/TIE PATHWAY IN RETINAL VASCULAR DISEASES-Reference-Cited by-同舟云学术

THE ANGIOPOIETIN/TIE PATHWAY IN RETINAL VASCULAR DISEASES

Published:2021-01 Issue:1 Volume:41 Page:1-19
ISSN:0275-004X
Container-title:Retina
language:en
Short-container-title:

Author:

Heier Jeffrey S.,Singh Rishi P.,Wykoff Charles C.,Csaky Karl G.,Lai Timothy Y.Y.,Loewenstein Anat,Schlottmann Patricio G.,Paris Liliana P.,Westenskow Peter D.,Quezada-Ruiz Carlos

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Ophthalmology,General Medicine

Reference82 articles.

1. Global causes of blindness and distance vision impairment 1990–2020: a systematic review and meta-analysis;Flaxman;Lancet Glob Health,2017

2. The prevalence of retinal vein occlusion: pooled data from population studies from the United States, Europe, Asia, and Australia;Rogers;Ophthalmology,2010

4. Anti-vascular endothelial growth factor therapy for diabetic macular edema;Boyer;Ther Adv Endocrinol Metab,2013

5. Diabetic retinopathy;Cheung;Lancet,2010

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Switch to faricimab after initial treatment with aflibercept in eyes with neovascular age-related macular degeneration;International Ophthalmology;2024-09-05

2. Dual pathway inhibition with faricimab for previously treated neovascular age-related macular degeneration and diabetic macular oedema: guidance from a UK panel of retina specialists;Eye;2024-08-30

3. Real-World Efficacy of Intravitreal Faricimab for Diabetic Macular Edema: A Systematic Review;Journal of Personalized Medicine;2024-08-28

4. Changes in Ocular Blood Flow After Intravitreal Injection for Diabetic Macular Edema Between Aflibercept and Faricimab;Clinical Ophthalmology;2024-08

5. Efficacy and Safety of Faricimab for Macular Edema due to Retinal Vein Occlusion;Ophthalmology;2024-08